Breast Cancer | Oncology Nursing News

To Know or Not to Know? Genetic Testing Is Beneficial in Breast Cancer

BY BRIELLE BENYON

Oral Rivaroxaban Reduces VTE in Outpatient Treatment of Patients With Cancer

BY KRISTIE L. KAHL

FDA Approves Atezolizumab Combo for Frontline TNBC

BY ONCLIVE STAFF

FDA Approves Subcutaneous Trastuzumab for Breast Cancer Subgroup

BY GINA COLUMBUS

FDA Warns Patients, Providers About Thermography Imaging to Diagnose Cancer

BY BRIELLE BENYON

Adherence With CDK 4/6 Inhibitors

BY PANELISTS: JOYCE OSHAUGHNESSY, MD; MICHAEL REFF, RPH, MBA; SARA M. TOLANEY, MD, MPH; LINDSAY SHAW, NP; KATE JEFFERS, PHARMD

Patient Management of CDK4/6 Inhibitors
BY PANELISTS: JOYCE OSHAUGHNESSY, MD; MICHAEL REFF, RPH, MBA; SARA M. TOLANEY, MD, MPH; LINDSAY SHAW, NP; KATE JEFFERS, PHARMD

Dispensing of CDK4/6 Inhibitors
BY PANELISTS: JOYCE OSHAUGHNESSY, MD; MICHAEL REFF, RPH, MBA; SARA M. TOLANEY, MD, MPH; LINDSAY SHAW, NP; KATE JEFFERS, PHARMD

Nurses Play Key Role in Susan G. Komen's Goal to Address Breast Cancer Disparities
BY KRISTIE L. KAHL

Multidisciplinary Approach: Managing CDK4/6 Inhibitors
BY PANELISTS: JOYCE OSHAUGHNESSY, MD; MICHAEL REFF, RPH, MBA; SARA M. TOLANEY, MD, MPH; LINDSAY SHAW, NP; KATE JEFFERS, PHARMD